|
||||||||
![]() |
||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
![]() Download
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
pHyPer-dMito is a mammalian expression vector encoding mitochondria-targeted HyPer (see HyPer description). HyPer codon usage is optimized for high expression in mammalian cells (humanized) [Haas et al., 1996]. Duplicated mitochondrial targeting sequence (MTS) is fused to the HyPer N-terminus. MTS was derived from the subunit VIII of human cytochrome C oxidase [Rizzuto et al., 1989; Rizzuto et al., 1995].
pHyPer-dMito can be used as a source of double-MTS-HyPer hybrid sequence. The vector backbone contains unique restriction sites that permit it excision and further insertion into expression vector of choice.
Note: The plasmid DNA was isolated from dam+-methylated E.coli. Therefore some restriction sites are blocked by methylation. If you wish to digest the vector using such sites you will need to transform the vector into a dam- host and make fresh DNA.
The vector backbone contains immediate early promoter of cytomegalovirus (PCMV IE) for reporter expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in E. coli and f1 origin for single-stranded DNA production. SV40 polyadenylation signals (SV40 poly A) direct proper processing of the 3'-end of the reporter mRNA.
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in E. coli. Kanr/Neor gene is linked with herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signals.
Expression in mammalian cells
pHyPer-dMito vector can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive expression of mitochondria-targeted HyPer in many cell types. If required, stable transformants can be selected using G418 [Gorman, 1985].
Propagation in E. coli
Suitable host strains for propagation in E. coli include DH5alpha, HB101, XL1-Blue, and other general purpose strains. Plasmid incompatibility group is pMB1/ColE1. The vector confers resistance to kanamycin (30 μg/ml) to E. coli hosts. Copy number in E. coli is about 500.
Location of features
PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
HyPer-dMito fusion
Start codon (ATG): 597-599
Mitochondrial localization signal 1 (MLS-1): 597-689
Mitochondrial localization signal 2 (MLS-2): 690-782
Start of Hyper coding sequence: 798-800
Stop codon: 2229-2231
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 2385-2390 & 2414-2419
mRNA 3' ends: 2423 & 2435
f1 single-strand DNA origin: 2482-2937
Eukaryotic promoter for expression of Kanr gene
-35 region: 2999-3004
-10 region: 3022-3027
Transcription start point: 3034
SV40 origin of replication: 3278-3413
SV40 early promoter
Enhancer (72-bp tandem repeats): 3111-3182 & 3183-3254
21-bp repeats: 3258-3278, 3279-3299 & 3301-3321
Early promoter element: 3334-3340
Major transcription start points: 3330, 3368, 3374 & 3379
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 3462-3464
Stop codon: 4254-4256
G->A mutation to remove Pst I site: 3644
C->A (Arg to Ser) mutation to remove BssH II site: 3990
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 4492-4497 & 4505-4510
pUC plasmid replication origin: 4841-5484
The HyPer-related materials (also referred to as "Products") are intended for research use only. These products are covered by Evrogen Patents and/or Patent applications pending.
The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.
To the best of our knowledge, these products do not require a Material Safety Data Sheet. However, all the properties of these products (and, if applicable, each of their components) have not been thoroughly investigated. Therefore, we recommend that you use gloves and eye protection, and wear a laboratory coat when working with these products.
|
Copyright 2002-2008 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, +7(495)4298020, e-mail:evrogen@evrogen.com |